Codexis (CDXS) Cash from Operations (2010 - 2026)
Codexis (CDXS) posted quarterly Cash from Operations of 13150000.0 for Q1 2026, up 4.7% year-over-year from 12560134.29 in Q1 2025, and down 165.45% quarter-over-quarter from 20092000.0 in Q4 2025.
Codexis (CDXS) Cash from Operations (2010 - 2026) Analysis & Trends
Codexis' Cash from Operations history runs 17 years deep, the most recent figure standing at 13150000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 4.7% year-over-year to 13150000.0; the TTM figure through Mar 2026 stood at 18728000.0 (up 66.21% YoY), while the FY2025 annual figure was 19376000.0, up 60.79% from the prior year.
- Cash from Operations for Q1 2026 stood at 13150000.0, down from 20092000.0 in the prior quarter.
- The five-year high for Cash from Operations was 20092000.0 in Q4 2025, with the low at 17967000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 11186000.0 (2022), against an average of 7252352.94.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations surged 10378.12% in 2022, then tumbled 637.6% in 2023.
- Codexis' Cash from Operations stood at 4917000.0 in 2022, then sank by 324.47% to 11037000.0 in 2023, then sank by 49.21% to 16468000.0 in 2024, then jumped by 222.01% to 20092000.0 in 2025, then plunged by 165.45% to 13150000.0 in 2026.
- Business Quant data shows CDXS's Cash from Operations at 13150000.0 in Q1 2026, 20092000.0 in Q4 2025, and 7703000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | -9.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.64 Mn |
| Jun 30, 2026 | -9.64 Mn |
| Mar 31, 2026 | -13.15 Mn |
| Mar 31, 2026 | -13.15 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Sep 30, 2025 | -7.70 Mn |
| Sep 30, 2025 | -7.70 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Mar 31, 2025 | -13.80 Mn |
| Mar 31, 2025 | -13.80 Mn |
| Dec 31, 2024 | -16.47 Mn |
| Dec 31, 2024 | -16.47 Mn |
| Sep 30, 2024 | -12.99 Mn |
| Sep 30, 2024 | -12.99 Mn |
| Jun 30, 2024 | -12.17 Mn |
| Jun 30, 2024 | -12.17 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Mar 31, 2024 | -7.79 Mn |